Access To Medicine In A Way The Industry Hasn't Seen Before

FUJIFILM Diosynth Biotechnologies is building the largest end-to-end CDMO facility for biologics in North America. Leaders from the organization share all the inside details of this project that is giving patients access to medicine in a way the industry has never seen before.

Designed with future growth in mind, the nearly 1,000,000 square-foot manufacturing site is being built with the flexibility to expand with additional 24 x 20,000 L bioreactors to accommodate new projects to meet the emerging needs of partners.